Zobrazeno 1 - 10
of 17
pro vyhledávání: '"K. J. Schjoedt"'
Autor:
Coen D.A. Stehouwer, Stine Elkjaer Nielsen, Frederik Persson, Kasper Rossing, Casper G. Schalkwijk, Hans-Henrik Parving, K. J. Schjoedt, Peter Rossing
Publikováno v:
Journal of the Renin-angiotensin-aldosterone System, 14(2), 161-166. SAGE Publications Inc.
Journal of the Renin-Angiotensin-Aldosterone System, Vol 14 (2013)
Journal of the Renin-Angiotensin-Aldosterone System, Vol 14 (2013)
Renin-angiotensin-aldosterone system (RAAS) blockade may reduce levels of biomarkers of chronic low-grade inflammation and endothelial dysfunction. We investigated the effect of spironolactone added to standard RAAS blockade on these biomarkers in an
Autor:
H. H. Parving, Peter Rossing, Anne Sofie Astrup, K. J. Schjoedt, Lise Tarnow, Peter Riis Hansen, Stine Elkjaer Nielsen, Maria Lajer
Publikováno v:
Diabetic Medicine. 27:1144-1150
Diabet. Med. 27, 1144–1150 (2010) Abstract Aims Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in Type 1 diabetic patients with different level
Autor:
Hans-Henrik Parving, K. J. Schjoedt, Maria Lajer, Tsuneharu Baba, Lise Tarnow, Peter Rossing, Anne Sofie Astrup, Takeshi Sugaya, Stine Elkjaer Nielsen
Publikováno v:
Diabetes Care
OBJECTIVE We studied tubular and glomerular damage in type 1 diabetic patients by measuring urinary–liver fatty acid binding protein (U-LFABP) and albuminuria. Subsequently, we evaluated the effect of ACE inhibition on U-LFABP in patients with diab
Autor:
Frans Boomsma, Anders Jorsal, Hans-Henrik Parving, Per K. Christensen, K. J. Schjoedt, Peter Rossing
Publikováno v:
Schjoedt, K J, Christensen, P K, Jorsal, A, Boomsma, F, Rossing, P & Parving, H-H 2009, ' Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes : a randomized crossover trial ', Nephrology, Dialysis, Transplantation, vol. 24, no. 11, pp. 3343-9 . https://doi.org/10.1093/ndt/gfp311
Nephrology Dialysis Transplantation, 24(11), 3343-3349. Oxford University Press
University of Copenhagen
Nephrology Dialysis Transplantation, 24(11), 3343-3349. Oxford University Press
University of Copenhagen
Background. Autoregulation of GFR, i.e. maintenance of relative constancy of GFR despite variations in mean arterial pressure (MAP) > 80 mmHg, is impaired in diabetic kidney disease; furthermore, some antihypertensive drugs may jeopardize autoregulat
Publikováno v:
Diabetologia. 51:956-961
In type 1 diabetic patients with microalbuminuria not receiving antihypertensive treatment, an increase in urinary AER (UAER) of 6-14%/year and a risk of developing diabetic nephropathy (DN) of 3-30%/year have been reported. We audited the long-term
Autor:
K. J. Schjoedt, Erik Frandsen, Frederik Persson, H.-H. Parving, Frans Boomsma, Casper G. Schalkwijk, Tina R. Juhl, Peter Rossing, Lise Tarnow, Coen D.A. Stehouwer
Publikováno v:
Kidney International, 73, 1419-25. Elsevier Science
Kidney International, 73(12), 1419-1425. Elsevier Inc.
Kidney International, 73(12), 1419-1425. Elsevier Inc.
Inhibition of renin with an active site inhibitor, aliskiren, lowers blood pressure (BP) in diabetic patients. Here, we studied the time course of the antihypertensive and antiproteinuric effect of renin inhibition in 15 patients with type 2 diabetes
Autor:
Lise Tarnow, Hans-Henrik Parving, Kasper Rossing, Tina R. Juhl, K. J. Schjoedt, Peter Rossing, Frans Boomsma
Publikováno v:
Kidney International, 70(3), 536-542. Elsevier Inc.
Reduction of nephrotic range albuminuria is associated with markedly improved renal and cardiovascular outcome in patients with diabetic nephropathy. Aldosterone has been suggested to play a role in the progression of diabetic nephropathy. We therefo
Publikováno v:
Diabetic Medicine. 23:675-680
Aims Aldosterone is one of the main effectors of the renin–angiotensin–aldosterone system regulating blood pressure. Previous studies have shown that the aldosterone synthase promoter polymorphism −344T/C influences aldosterone levels and is as
Publikováno v:
Kidney International. 68(3):1190-1198
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and miroalbuminuria.BackgroundThe purpose of this study was to evaluate the renoprotective effect as reflected by short-term changes in albuminuria of u
Publikováno v:
Diabetes Care. 28:2106-2112
OBJECTIVE—The objective of this study was to evaluate the safety and short-term effect of adding spironolactone to conventional antihypertensive treatment including diuretics and maximally recommended doses of an ACE inhibitor or an angiotensin II